Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-13 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +632,500 632,500
2022-12-28 Silver Brian M. Chief Financial Officer Purchase +3,158 $1.56 $5K 32,885
2022-12-27 Silver Brian M. Chief Financial Officer Purchase +2,842 $1.50 $4K 29,727
2022-07-25 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +220,000 220,000
2022-03-24 Silver Brian M. Chief Financial Officer Purchase +15,000 $3.40 $51K 26,885
2022-01-18 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2021-09-21 Silver Brian M. Chief Financial Officer Purchase +5,000 $6.32 $32K 11,885
2021-09-09 Silver Brian M. Chief Financial Officer Purchase +5,885 $8.48 $50K 6,885
2021-07-20 Silver Brian M. Chief Financial Officer Purchase +1,000 $15.00 $15K 1,000
2021-07-15 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (right to buy) +250,441 250,441

Page 1 of 1 · 10 trades